Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

AIMP1 can boost hair growth by increasing stem cell activity.

Lower Paraoxonase 1 levels in alopecia areata patients suggest antioxidant treatment might help.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Low PON1 levels may indicate and predict the severity of hair loss.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

New genetic mutations causing hair loss were found in a Chinese family.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Aromatase gene variation may increase female hair loss risk.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Targeting the AhR pathway may help treat alopecia areata.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

New and known mutations in the hairless gene cause a hair loss condition called Atrichia with papular lesions.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Human hair contains a substance that shows blood group A activity.

Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.